Healthtech Startups

Outlook Therapeutics develops ophthalmic therapies for retinal diseases, including anti-VEGF treatments for conditions such as neovascular (wet) age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion. Its lead product, LYTENAVA (bevacizumab-vikg), is an FDA-approved ophthalmic bevacizumab formulation for adults with wet AMD.

1 investor

A platform that combines athlete assessment, velocity-based training guidance, and performance data analysis to help strength and conditioning professionals design and manage training programs. It integrates real-time biometric feedback with program management for individual athletes and teams.

1 investor

Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers. The company manufactures in North America and operates across the United States.

1 investor

Overdrive Health provides AI-powered medical billing services that automate the revenue cycle for healthcare providers, including insurance discovery, eligibility verification, coding, claims submission, and denial management. The platform combines automated technology with human oversight to reduce administrative burden and improve billing efficiency for medical practices.

1 investor

Overseed is a French company developing medical cannabis treatments, from plant cultivation to finished medicines, to address patient pain, anxiety, and spasticity. It works on pharmaceutical-grade formulations such as oral oils, inhalables, and sublingual sprays, in partnership with the CNRS and university hospitals, for the French regulated medical cannabis market.

1 investor

Overture develops precision antibody therapeutics for obesity treatment, targeting metabolic dysfunction pathways to reduce fat mass while preserving lean muscle through monthly-dosed therapeutic approaches.

1 investor

Ovianta is an AI platform for medical clinics and hospitals that deploys voice agents and automated workflows to handle patient calls, appointment scheduling, reminders, waitlist filling, and outreach campaigns via phone or WhatsApp. It integrates with clinic-management systems and telephony, enriches patient records, and provides analytics dashboards, with support for Spanish clinic systems and GDPR compliance.

1 investor

Ownmed Innovation is a spin-off that develops medical devices and technologies to address unmet clinical needs, taking products through preclinical studies, clinical trials, and CE certification under EU regulation 2017/745. Its focus includes ostomy care, with a device aimed at restoring continence.

1 investor

OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.

1 investor

Oxford provides AI advisory and consulting services, helping organizations with AI strategy, governance, readiness assessment, pilot execution, and adoption planning to move from experimentation to measurable business value. It supports enterprise clients across the full AI lifecycle through staffing, co-managed, or full delivery engagement models.

1 investor

Oxurion is a French specialist in clinical biometrics and data management, providing the core technology for the Oxurion platform.

1 investor

OxVent designs and produces a low-cost electro-mechanical medical ventilator, originally developed for the UK Government's 2020 Ventilator Challenge by engineers and medics from the University of Oxford and King's College London. Operating as a social venture, the company deploys its ventilator for use during and beyond the COVID-19 pandemic.

1 investor

OxyPrem develops non-invasive sensors that provide real-time monitoring of oxygen levels in human tissue, aimed at neonatal intensive care and the treatment of premature and other vulnerable patients. Its technology targets clinical teams, with an early focus on the Swiss NICU market.

1 investor

oyora operates a network of medical facilities offering interdisciplinary diagnostics and treatment, with a focus on radiology using cross-sectional imaging equipment. It coordinates specialists across locations to provide patient care in Germany, open to patients regardless of insurance type.

1 investor

P95 is a clinical research and pharmaceutical services company that supports pharmaceutical development through medical monitoring, epidemiology, biostatistics, study management, pharmacovigilance, and medical writing services.

1 investor

A consumer wellness brand developing microbiome-support solutions, founded by a scientist who is also a user of the products.

1 investor

P-Mind develops non-invasive therapeutic technologies based on decades of research into magnetic fields and their interaction with living organisms, with a focus on treating pain disorders, neurological diseases, and cancer. The company manufactures and sells medical devices, including the alternating magnetic field therapy device "Eight" (エイト).

1 investor

P3 Therapeutics is developing a new class of anti-inflammatory small chemical molecules and works with partners on a humanized gut-entheseal organ-on-chip platform to study their mechanism of action, pharmacokinetics, pharmacodynamics, and biomarkers. The work is part of an application to the EUROSTARS 3 program under the TRIGG3R project.

1 investor

Pacific Biosciences manufactures consumables and reagent kits for long-read DNA and RNA sequencing platforms, serving genomics research and diagnostics labs.

1 investor

Pace provides laboratory testing services to help customers assess environmental safety and health risks. Founded in 1978, the company serves organizations needing accurate testing and is committed to sustainable practices and regulatory compliance.

1 investor

PaceMate operates a cloud-based platform for remote cardiac implantable electronic device (CIED) monitoring, aggregating data from cardiac devices and EHRs to manage patient triage, workflows, clinical research, and billing. It serves U.S. health systems and cardiac device clinics, with integrations across major EHR platforms and a research-grade CIED dataset.

1 investor

Pacesetter Health is a physician-led management services organization that partners with podiatry practices, handling non-clinical operations such as billing, compliance, HR, credentialing, EMR/IT systems, and marketing so podiatrists can focus on patient care. It also invests in partner practices to support growth, succession planning, and facility expansion across the United States.

1 investor

Pac8 is a venture capital firm that invests at the seed stage in technology platforms applied to healthcare, including therapeutics, diagnostics, and health services, typically as the first institutional investor. It focuses mainly on the US market.

1 investor

Pacific Pharmacy Group is a group of independent community pharmacies providing pharmacy and healthcare services to local communities. It also hosts pharmacy residency programs for post-graduate students interested in independent pharmacy practice.

1 investor